Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marieke F Fransen

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Biomaterials|December 3, 2014
Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen-specific CD8(+) T cell immune responseSima Rahimian, Jan Willem Kleinovink, Marieke F Fransen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2014
IgG-mediated anaphylaxis to a synthetic long peptide vaccine containing a B cell epitope can be avoided by slow-release formulationEsther D Quakkelaar, Marieke F Fransen, Wendy W C van Maren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Maintenance of immune tolerance depends on normal tissue homeostasisZita F H M Boonman, Geertje J D van Mierlo, Marieke F Fransen, et al.
Oncotarget|July 24, 2018
FcγRI expression on macrophages is required for antibody-mediated tumor protection by cytomegalovirus-based vaccinesHreinn Benonisson, Heng Sheng Sow, Cor Breukel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2002
CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunityGeertje J D van Mierlo, Annemieke Th den Boer, Jan Paul Medema, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reactionZita F H M Boonman, Geertje J D van Mierlo, Marieke F Fransen, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLCEzgi B Ulas, Sofie J I Koomen, Anne Vrijmoet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradicationGeertje J D van Mierlo, Zita F H M Boonman, Hélène M H Dumortier, et al.
Cell Reports. Medicine|December 21, 2023
Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysisNorbert Moldovan, Ymke van der Pol, Tom van den Ende, et al.
International Journal of Cancer|September 28, 2018
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor modelHeng Sheng Sow, Hreinn Benonisson, Cor Breukel, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Biomaterials|December 3, 2014
Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen-specific CD8(+) T cell immune responseSima Rahimian, Jan Willem Kleinovink, Marieke F Fransen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2014
IgG-mediated anaphylaxis to a synthetic long peptide vaccine containing a B cell epitope can be avoided by slow-release formulationEsther D Quakkelaar, Marieke F Fransen, Wendy W C van Maren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
Maintenance of immune tolerance depends on normal tissue homeostasisZita F H M Boonman, Geertje J D van Mierlo, Marieke F Fransen, et al.
Oncotarget|July 24, 2018
FcγRI expression on macrophages is required for antibody-mediated tumor protection by cytomegalovirus-based vaccinesHreinn Benonisson, Heng Sheng Sow, Cor Breukel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2002
CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunityGeertje J D van Mierlo, Annemieke Th den Boer, Jan Paul Medema, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reactionZita F H M Boonman, Geertje J D van Mierlo, Marieke F Fransen, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLCEzgi B Ulas, Sofie J I Koomen, Anne Vrijmoet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradicationGeertje J D van Mierlo, Zita F H M Boonman, Hélène M H Dumortier, et al.
Cell Reports. Medicine|December 21, 2023
Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysisNorbert Moldovan, Ymke van der Pol, Tom van den Ende, et al.
International Journal of Cancer|September 28, 2018
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor modelHeng Sheng Sow, Hreinn Benonisson, Cor Breukel, et al.
Pageof 6